Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Infection01:20

Infection

When a pathogen enters the body and reproduces, it can cause an infection, damage body cells, and cause illness symptoms that eventually lead to disease. Therefore, its prevention requires breaking the chain of infection.
The chain begins with pathogens: bacteria, viruses, fungi, prions, or parasites such as protozoa helminths. These can be present on the skin as transient or resident flora, or they can be acquired from the environment. Identifying and treating the type of infection and...
Microbial Interactions: Parasitism01:22

Microbial Interactions: Parasitism

Parasitism is a form of microbial interaction in which parasitic microbes exploit a host organism for nutrients and shelter, often at the host's expense. Unlike mutualistic relationships, where both organisms benefit, parasitism benefits only the parasite and harms the host.Classification of ParasitesMicrobial parasites are broadly classified based on their location relative to the host.Ectoparasites remain on the host’s surface, such as the skin or outer tissues, drawing nutrients...
Colonisation of Pathogens01:25

Colonisation of Pathogens

Pathogen colonization of host tissues is a critical step in the development of infectious diseases. Various pathogenic microorganisms, including bacteria, fungi, viruses, and protozoa, have evolved complex strategies to attach to, invade, and persist within host environments. These mechanisms enable pathogens to establish infections, evade immune responses, and resist antimicrobial treatments.Attachment to Host CellsIn bacteria, colonization typically begins with adherence to host epithelial...
Factors Affecting the Risk of Infection01:26

Factors Affecting the Risk of Infection

The hosts' susceptibility to infection depends on several factors. The integrity of the skin and mucous membranes helps protect the body against microbial attacks. When the skin is altered, the chance of infection, limb loss, and even death increases.
The integrity and count of the white blood cells help the body resist pathogens and fight infection. When impaired, it reduces the body's resistance to pathogens. The acidic pH levels of the gastrointestinal, genitourinary tracts, and skin create...
Reservoir of Infection01:30

Reservoir of Infection

Infectious diseases arise from intricate interactions between pathogens and their reservoirs. A reservoir of infection refers to the natural habitat where a pathogen lives, grows, and multiplies, serving as a continual source of infection. Reservoirs are broadly classified as either living or nonliving, and each plays a unique role in disease transmission, significantly influencing public health interventions and control strategies.Humans act as reservoirs for a wide array of pathogens,...
Determinants of Bacterial Pathogenicity and Virulence01:20

Determinants of Bacterial Pathogenicity and Virulence

Pathogenic bacteria employ a variety of strategies to establish infections, including the secretion of extracellular enzymes that act as potent virulence factors. These enzymes facilitate bacterial colonization of host tissues and help evade immune surveillance. By targeting structural components of host tissues and interfering with immune mechanisms, these enzymes play a pivotal role in disease progression.Extracellular Enzymes Facilitating Tissue Invasion: Several bacterial pathogens secrete...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Ameliorating chronic pain: opioids, adjunct and alternative therapies.

Inflammopharmacology·2016
Same author

Preface. Novel Natural Products: Therapeutic Effects in Pain Arthritis and Gastro-intestinal Diseases.

Progress in drug research. Fortschritte der Arzneimittelforschung. Progres des recherches pharmaceutiques·2015
Same author

Some applications of pharmacogenomics and epigenetics in drug development and use in pursuit of personalized medicine.

Inflammopharmacology·2012
Same author

A toxicological investigation of a celery seed extract having anti-inflammatory activity.

Inflammopharmacology·2010
Same author

International conference on inflammopharmacology and sixth symposium on side-effects of anti-inflammatory drugs.

Inflammopharmacology·2007
Same author

Stress protein synthesis in human keratinocytes treated with sodium arsenite, phenyldichloroarsine, and nitrogen mustard.

Fundamental and applied toxicology : official journal of the Society of Toxicology·1990

Related Experiment Video

Updated: Jul 13, 2026

Determination of Biofilm Initiation on Virus-infected Cells by Bacteria and Fungi
12:33

Determination of Biofilm Initiation on Virus-infected Cells by Bacteria and Fungi

Published on: July 6, 2016

Persons and pathogens: consequences of co-existence.

M C Powanda1

  • 1M/P Biomedical Consultants LLC, 94941, Mill Valley, California, USA. mpbiomed@slip.net

Inflammopharmacology
|July 20, 2007
PubMed
Summary

Infectious agents may cause chronic inflammatory diseases, cancers, and neurologic conditions. Research explores if targeting infections or using long-term NSAIDs (nonsteroidal anti-inflammatory drugs) offers better prevention and treatment strategies.

Area of Science:

  • Infectious disease epidemiology
  • Chronic disease pathogenesis
  • Pharmacology

Background:

  • Infectious agents are increasingly implicated as cofactors or causes of chronic inflammatory diseases, cancers, and neurologic disorders.
  • Evidence suggests infectious antecedents may underlie numerous inflammatory conditions and specific diseases.
  • This raises questions about alternative treatment strategies focusing on the infectious source.

Purpose of the Study:

  • To explore the role of infectious agents in chronic diseases.
  • To evaluate the potential of targeting infectious antecedents versus treating consequent diseases.
  • To consider the utility of novel antibiotic/anti-inflammatory drugs versus preventive measures like improved sanitation and vaccines.

Main Methods:

  • Review of evidence linking infectious agents to chronic diseases.

More Related Videos

Studying Microbial Communities In Vivo: A Model of Host-mediated Interaction Between Candida Albicans and Pseudomonas Aeruginosa in the Airways
06:43

Studying Microbial Communities In Vivo: A Model of Host-mediated Interaction Between Candida Albicans and Pseudomonas Aeruginosa in the Airways

Published on: January 13, 2016

Kinetic Visualization of Single-Cell Interspecies Bacterial Interactions
08:33

Kinetic Visualization of Single-Cell Interspecies Bacterial Interactions

Published on: August 5, 2020

Related Experiment Videos

Last Updated: Jul 13, 2026

Determination of Biofilm Initiation on Virus-infected Cells by Bacteria and Fungi
12:33

Determination of Biofilm Initiation on Virus-infected Cells by Bacteria and Fungi

Published on: July 6, 2016

Studying Microbial Communities In Vivo: A Model of Host-mediated Interaction Between Candida Albicans and Pseudomonas Aeruginosa in the Airways
06:43

Studying Microbial Communities In Vivo: A Model of Host-mediated Interaction Between Candida Albicans and Pseudomonas Aeruginosa in the Airways

Published on: January 13, 2016

Kinetic Visualization of Single-Cell Interspecies Bacterial Interactions
08:33

Kinetic Visualization of Single-Cell Interspecies Bacterial Interactions

Published on: August 5, 2020

  • Discussion of therapeutic strategies, including antibiotics, anti-inflammatories, and vaccines.
  • Analysis of studies on the long-term use of nonsteroidal anti-inflammatory drugs (NSAIDs), including aspirin, for disease prevention.
  • Main Results:

    • Long-term NSAID use, particularly aspirin, may reduce the incidence of certain chronic inflammatory, neurologic, and cancerous diseases.
    • Preventive measures like enhanced food handling, water treatment, and vaccination are proposed as cost-effective approaches.

    Conclusions:

    • The potential benefits and risks of lifelong NSAID/aspirin intake require careful consideration.
    • Establishing a robust database is crucial for estimating the risk-benefit ratio of extended NSAID use for disease prevention.
    • Further research is needed to determine optimal strategies for managing or preventing diseases with infectious origins.